Actemra (Tocilizumab) 162 mg/0.9 mL Solution for Subcutaneous Injection

Actemra is a biologic medication containing Tocilizumab, provided in pre-filled syringes for subcutaneous injection to manage inflammatory conditions.

EGP 28,000

In Stock

Delivery to governorates within 3-4 working days

Easy returns within 14 days

Specifications

SKU	CT-77
Color	Luscious Blackberry

About the product›

About Actemra (Tocilizumab) 162 mg

Actemra, as shown in the provided image, is a specialized prescription-only medicine containing the active ingredient Tocilizumab (rch). It is formulated as a solution for subcutaneous injection, offering a targeted approach to managing inflammatory diseases.

Therapeutic Use

Tocilizumab is a monoclonal antibody that inhibits the interleukin-6 (IL-6) receptor, effectively reducing inflammation associated with various autoimmune and inflammatory conditions.

Key Product Features

Dosage: 162 mg per 0.9 mL solution.
Administration: Designed for subcutaneous injection.
Presentation: The carton contains 4 pre-filled syringes for convenient use.
Manufacturer: Produced by Roche, ensuring pharmaceutical quality and reliability.

This product is a prescription-only medicine. Please keep out of reach of children and follow your physician's instructions carefully for administration and storage.